B3 Consulting Group

B3 Consulting Group

Sälj aktien Köp aktien Handla aktien direkt på nordnet

« Tillbaka

B3 Consulting Group - Margin beat on cost cuts

20 februari 2026

  • Sales -9% but adj. EBITA +7% vs. consensus
  • Margin improvement supported by cost efforts and Habberstad
  • Consensus EBITA estimates likely down by mid single-digits

Q4'25 report

B3 reported Q4'25 sales of SEK 315m (-8% vs. ABGSCe 343m, -9% vs. FactSet consensus), representing an organic decline of 14%. The decline was primarily driven by fewer B3 consultants and subcontractors. Two, slightly offsetting factors were higher hourly prices and utilisation rates. Adj. EBITA came in at SEK 17m (+8% vs. ABGSCe 16m, +7% vs. consensus), representing a margin of 5.4%, which was better than we expected, but it was also cost-driven. More specifically, it was due to lower overhead costs in Sweden.

Thoughts and outlook

The market environment remains soft, with negative net recruitment and cautious customer behaviour. However, B3 has adjusted its cost base relatively meaningfully as avg. FTEs declined ~10% y-o-y to 899 (1,005). While volumes remain somewhat soft in Sweden, the operations in Poland and Norway should help support earnings growth going forward.

Consensus estimate revisions

On our unrevised estimates, B3 is trading at 5x '26e EV/EBITA. Mechanically, the impact on consensus EBITA estimates should be within a negative mid single-digit range when considering the reduced number of consultants and the somewhat lower overhead costs that offset the negative impact a bit. A presentation by the company will be hosted at 9.00 CET (link).

Deviation table
Source: ABG Sundal Collier, FactSet, Company data.

Senaste artiklar från alla bolag

Datum Titel Bolag Typ
2026-03-12 StrongPoint - Investor update StrongPoint Analys
2026-03-08 Medicover - From build-out to fill-up Medicover Analys
2026-03-02 Qben Infra - Portfolio reshaping continues Qben Infra Analys
2026-02-27 Xplora Technologies - Record quarter driven by Se... Xplora Tech.. Analys
2026-02-24 Isofol Medical - From first lessons to second exe... Isofol Medical Analys
2026-02-24 B3 Consulting Group - Cost adjustments should lif... B3 Consulti.. Analys
2026-02-23 Ework Group - Market conditions yet to improve Ework Group Analys
2026-02-23 Formpipe - Good margins, but ACV lags Formpipe Analys
2026-02-23 Energy Save - Back to growth, but softer H1'26 ex... Energy Save Analys
2026-02-23 Fastpartner - Outlook taking a hit Fastpartner Analys
2026-02-23 Cavotec - Industry shines in cautious environment Cavotec Analys
2026-02-20 Arctic Paper - Still challenging Arctic Paper Analys
2026-02-20 Inission - Set for substantial earnings growth Inission Analys
2026-02-20 BTS Group - Ahead of plan on growth recovery BTS Group Analys
2026-02-20 Energy Save - OEM sales up, softer start to '26 e... Energy Save Analys
2026-02-20 Formpipe - Weaker ACV, but higher dividends Formpipe Analys
2026-02-20 B3 Consulting Group - Margin beat on cost cuts B3 Consulti.. Analys
2026-02-20 BTS Group - North America behind Q4 miss BTS Group Analys
2026-02-20 Skolon - Q4'25 momentum to also pay off in H1'26 Skolon Analys
2026-02-20 Ogunsen - Easier comps await in '26e Ogunsen Analys